Our Media - COVID-19 clinical trial impact and potential mitigation
Latest content from Pharmetheus.
COVID-19 clinical trial impact and potential mitigation
Fewer subjects, shorter duration, missingness patterns and dosing interruptions.
September 12, 2020
The ongoing pandemic continues to influence the conduct of clinical trials in all therapeutic areas. In this video, our Chief Statistician Richard Anziano describes how the COVID-19 impact on studies can be understood and mitigated, using modeling and simulation approaches.
